NCT00042497暂停2 期
A Phase II, Multicenter, Open-Labeled Study of Immunotherapy With Autologous Dexosomes for Patients With Stage IV Melanoma
适应症
试验速览
- 阶段
- 2 期
- 状态
- 暂停
- 发起方
- Anosys
- 入组人数
- 60
研究概览
简要总结
The objective is to determine the safety and efficacy of dexosome immunotherapy in patients with Stage IV malignant melanoma
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with Stage IV metastatic melanoma with 0-1 prior treatments for metastatic disease.
- •All patients must have distant skin, subcutaneous, or nodal metastases (M1a) or lung metastases (M1b), measurable disease, normal lactate dehydrogenase levels, and HLA type A1, A2, or B
- •Patients must have adequate organ function and an estimated life expectancy of at least 3 months.
排除标准
- 未提供
研究者
相似试验
已完成
2 期
Safety and Efficacy Therapy of Gemcitabine and Erbitux® to R0 or R1 Resected Pancreatic CancerAdenocarcinomaNCT00395252Carmen Schade-Brittinger76
招募中
1 期
A Study of SHR-1802 in Combination With Adebrelimab in Patients With Advanced Solid TumorsAdvanced Solid TumorNCT05794477Shanghai Hengrui Pharmaceutical Co., Ltd.132
进行中（未招募）
2 期
A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With Recurrent Metastatic Nasopharyngeal CarcinomaRecurrent or Metastatic Nasopharyngeal CarcinomaNCT05126719Lepu Biopharma Co., Ltd.238
已完成
2 期
Safety and Immunogenicity of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in HIV Infected PatientsHIV InfectionsNCT00316589Bavarian Nordic581
已完成
2 期
Efficacy and Safety Study of KN019 in Rheumatoid Arthritis Patients With an Inadequate Response to MethotrexateRheumatoid ArthritisNCT04038970Jiangsu Alphamab Biopharmaceuticals Co., Ltd145